Valuation : Biogen Inc.

Market Cap 31.4B 27B 25.4B 23.18B 43.25B 2,977B 43.48B 301B 116B 1,521B 118B 115B 4,842B P/E 2026 *
36.7x
P/E 2027 * 19x
Enterprise Value 36.33B 31.24B 29.39B 26.82B 50.05B 3,445B 50.31B 348B 135B 1,761B 136B 133B 5,603B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.17x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.10%
1 week-4.30%
Current month-1.65%
1 month+2.88%
3 months+7.02%
6 months+13.20%
Current year+21.08%
1 week 209
Extreme 209
225.8
1 month 201
Extreme 201
225.8
Current year 160.36
Extreme 160.3645
225.8
1 year 135.39
Extreme 135.39
225.8
3 years 110.04
Extreme 110.035
269.43
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

General Counsel

7,405 0.0050%
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-4.30%+48.39%-17.70% 31.4B
-0.93%-5.60%+44.53%-3.50% 80.91B
-0.78%-0.64%-19.76%-36.79% 60.46B
-2.06%-8.80%+462.09%+30.00% 56.02B
+0.83%-4.47%-8.40%+30.44% 49.63B
-1.11%-7.21%-2.15%+148.24% 45.88B
+1.56%-1.71%+47.93%+96.60% 25.22B
-2.00%-3.35%-2.29%+177.79% 22.25B
-3.02%-2.59%+60.23%+99.82% 16.59B
+0.90%-7.14%-23.99%+726.73% 14.38B
Average -0.64%-1.28%+60.66%+125.16% 40.27B
Weighted average by Cap. -0.70%-1.14%+77.26%+63.13%

Financials

2026 *2027 *
Net sales 10.44B 8.98B 8.45B 7.71B 14.39B 990B 14.46B 100B 38.73B 506B 39.22B 38.36B 1,610B 10.66B 9.16B 8.62B 7.87B 14.68B 1,010B 14.76B 102B 39.51B 516B 40.01B 39.14B 1,643B
Net income 964M 829M 780M 711M 1.33B 91.38B 1.33B 9.24B 3.57B 46.7B 3.62B 3.54B 149B 1.86B 1.6B 1.5B 1.37B 2.56B 176B 2.57B 17.78B 6.88B 89.91B 6.97B 6.82B 286B
Net Debt 4.94B 4.24B 3.99B 3.64B 6.8B 468B 6.84B 47.31B 18.31B 239B 18.54B 18.13B 761B 2.42B 2.08B 1.96B 1.79B 3.33B 229B 3.35B 23.19B 8.97B 117B 9.09B 8.89B 373B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
09/09/26 US$213.04 +0.25% 167,028
08/09/26 US$212.50 -3.77% 617,829
04/09/26 US$220.83 -1.64% 465,108
03/09/26 US$224.51 +0.83% 550,745
02/09/26 US$222.67 +3.07% 1,268,282
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
212.50USD
Average target price
236.87USD
Spread / Average Target
+11.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!